Current position:Home >Product >
2,6-dibutyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-pyrimidin-4-one
2,6-dibutyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-pyrimidin-4-one(135689-23-5)
- Name: 2,6-dibutyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-pyrimidin-4-one
- Synonyms:
- Molecular Formula:C26H30N6O
- Molecular Weight:442.556
- CAS Registry Number:135689-23-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.135689-23-5 CGP 48369
Assay:98% Appearance:Powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:Cgp 48369 is a nonpeptide a angiotensin type 1 receptor antagonist originated by Novartis. Treatmenf for for Hypertension in Switzerland was discontinued in 1995.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 60202-37-1/C.I.Reactive Blue 105
- 157382-15-5/Poly[oxy(methyl-1,2-ethanediyl)],a-[2-[bis[2-hydroxy-3-[(2-methyl-1-oxo-2-propen-1-yl)oxy]propyl]amino]methylethyl]-w-[2-[bis[2-hydroxy-3-[(2-methyl-1-oxo-2-propen-1-yl)oxy]propyl]amino]methylethoxy]-
- 153804-66-1/1-(3,4-dihydro-2H-thiochromen-8-yloxy)-3-(tricyclo[3.3.1.1~3,7~]dec-1-ylamino)propan-2-ol
- 52995-53-6/5-(4-Carboxy-1H-1,2,3-triazol-1-yl)-5-deoxythymidine
- 69640-77-3/4H,8H-Benzo[1,2-b:3,4-b']dipyran-4-one,2,3-dihydro-5-hydroxy-8,8-dimethyl-2-phenyl-, (2S)-
- 770-37-6/2-(benzylideneamino)ethanol
- 7076-83-7/tricyclo[3.2.1.0~2,4~]octan-8-one
- 38914-94-2/4-Quinolineamine, N-(2-((2-chloroethyl)thio)ethyl)-7-(trifluoromethyl) -, hydrochloride
- 58039-75-1/2-[2-(2-methylphenyl)ethyl]morpholine (2E)-but-2-enedioate (2:1)
- 65167-63-7/S-[2-(dipropan-2-ylamino)ethyl] O-ethyl methylphosphonothioate
- 146925-27-1/cochinmicin V
- 138112-91-1/3,5-dichloro-N-[2-(7-methoxynaphthalen-1-yl)ethyl]benzamide
- 65104-91-8/Poly[oxy(methyl-1,2-ethanediyl)],a-[[[methyl-3-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]phenyl]amino]carbonyl]-w-[[[[methyl-3-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]phenyl]amino]carbonyl]oxy]-
- 5113-68-8/(2Z)-1-(2,4-dinitrophenyl)-2-[5-methyl-2-(1-methylethyl)cyclohex-2-en-1-ylidene]hydrazine
- 15491-18-6/Hopeite(Zn3(PO4)2.4H2O) (9CI)
- 6946-18-5/heptopyranose
- 25757-16-8/Phosphonic diiodide(8CI,9CI)
- 65104-04-3/Phenol, 4-methyl-, polymer with diethenylbenzene and 1-ethenyl-4-ethylbenzene
- 121820-50-6/desertomycin A
- 135689-23-5/2,6-dibutyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1H-pyrimidin-4-one
- 102433-47-6/1-(2-Chloroethyl)-3-(1,3-diphenyl-2-propyl)urea
- 84560-02-1/4-[[[5-(dimethylamino)-1-naphthyl]sulphonyl]amino]butyric acid, compound with cyclohexylamine (1:1)
- 72365-59-4/4-(methylamino)-4-oxo-3-phenylbutanoic acid
- 86145-84-8/(5Z)-5-[(2-hydroxyphenyl)methylidene]-2-(4-methoxyphenyl)-2-methyl-3-phenyl-1,3-thiazolidin-4-one
- 90268-73-8/2-Butenoic acid, 2,3-dichloro-4-oxo-, reaction products with Et alc. and ethanolamine
- 59935-47-6/N-2-fluorenylsuccinamic acid
- 68039-72-5/2-methyl-1,3-dioxolan-2-ylethyl acetate
- 83248-46-8/(2S)-3-[(1E,3E,5E,7E,9E)-dodeca-1,3,5,7,9-pentaen-1-yloxy]propane-1,2-diol
- 5765-70-8/(5Z)-5-[(5-acetylfuran-2-yl)methylidene]-3-methyl-2-thioxo-1,3-thiazolidin-4-one
- 6289-09-4/6-chloro-1-phenyl-N-propyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine